SOLUBLE URANIUM DEFINITION FOR REGULATORY COMPLIANCE

Similar documents
23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

Lecture 9 PCL201 Drug Distribution

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.

Dosage Administration

Impacts of State Level Dental Hygienist Scope of Practice on Oral Health Outcomes in the U.S. Population

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Commissioning Policy: South Warwickshire CCG (SWCCG)

Ontario 2018 provincial election issues backgrounder

Generic Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations

2017 Optum, Inc. All rights reserved BH1124_112017

FDA Dietary Supplement cgmp

Nutritional Intervention Effectiveness in Oncology Patients Receiving Active Anti-Cancer Treatment: A Systematic Review

April 23, 2008 Information Sheet: Safety of BPA-derived Can Liners. Summary

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

Urine Alkalinization. Passawat Na Nakorn, MD. R 3 Emergency Medicine

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Osteoporosis Fast Facts

Annex III. Amendments to relevant sections of the Product Information

CLINICAL MEDICAL POLICY

Program Design - Addressing Common Errors

LTCH QUALITY REPORTING PROGRAM

WCPT awards programme 2015

Nonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent

Risk factors in health and disease

Reliability and Validity Plan 2017

WHAT IS HEAD AND NECK CANCER FACT SHEET

Lesson Unit content* Activities Resource checklist Links to other units

DEMENTIA. DESCRIPTION: a progressive, degenerative disease of the brain, which causes impairment of thinking and memory

Position of Working Group 3 on the IPR provisions in the field of source apportionment

Related Policies None

Statement of Work for Linked Data Consulting Services

The demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

Biology 30S Unit Test Review: Digestion

Access to Heme Treatment in Canada - Survey 2018

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

Top 10 Causes of Disability

Diabetes: HbA1c Poor Control (NQF 0059)

SECTION O. MEDICATIONS

GENERAL / VASCULAR SONOGRAPHY OPTION COURSE OUTLINE AURORA ST. LUKE S MEDICAL CENTER SCHOOL OF DIAGNOSTIC MEDICAL SONOGRAPHY COURSE OVERVIEW

BIOLOGY 101. CHAPTER 7: Membrane Structure and Function: Life at the Edge

Radiographic Procedures I Laboratory. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses

Test 3 Study Guide: Photosynthesis, Respiration, and the Cell Membrane

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Talking to Patients About Recreational Cannabis

ITQ ARTS AND SCIENCE INTEGRATION GRADE 5 DANCE AND LIFE SCIENCE. All Systems, GO! Lesson #3

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

D E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y

Photomedicine Devices And Technologies Market Size, Share & Trends Analysis Report and Segment Forecast, 2024 Grand View Research, Inc

Building Code 101 OWMC November 20, Ministry of Municipal Affairs and Housing

Neonatal Jaundice Guideline

Extraction of oleic acid from jojoba oil, soybean oil and olive oil Phase diagrams

Taste-sickness associations in youngrats over varying delays, stimulus, and test conditions

BIOLOGY 101. CHAPTER 13: Meiosis and Sexual Life Cycles: Variations on a Theme

M.R.C.Path. causes to the raised plasma urea in patients admitted

Immunology and Immunotoxicity of Nanomedicines

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Food information to consumers - Commission proposal - COM (2008) 40 final 2008/0028 (COD) The European Heart Network s position in a nutshell

The data refer to persons aged between 15 and 54.

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

Social Learning Theories

INTERIM REPORT JANUARY SEPTEMBER 2017

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study

J P Gupta, P V Joshi, P V N Nair & K S V Nambi Environmental Assessment Division, Bhabha Atomic Research Centre, Trombay, Bombay , India

CDC Influenza Division Key Points MMWR Updates February 20, 2014

Cardiac Rehabilitation Services

Upper airway obstruction (UAO)

Cancer Association of South Africa (CANSA)

BRCA1 and BRCA2 Mutations

Prokaryotic cells are placed in two taxonomic domains: o Bacteria o Archaea o

Administrstrative Procedure

Intravenous Fluid & Acidbase Balance for Surgical. Patients

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 5 (September/October 2007)

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

Catherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support

Call Routing in the NG9-1-1 World

2016 CWA Political Action Fund Administrative Procedures Checklist

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

LUPIN LIMITED SAFETY DATA SHEET

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

For personal use only

CARDIOVASCULAR SYSTEM: OVERVIEW & ANATOMY Cathy Proenza

OTHER AND UNSPECIFIED DISORDERS

Guidance for Applicants to the Global fund to Fight AIDS, TB and Malaria Round 8 Call for proposals 28 February 2008

METHYL TESTOSTERONE IN PREMATURE INFANTS

Press Release. Adocia Reports Operational and Financial Results for the First Half of 2014

Cross-Platform Comparison of IL-6 Immunoassays. Maribeth Raines, PhD. Vice President of Laboratory Services. May 17, 2016 Biomarker World Congress

SCALES NW HEARING PROTECTION PROGRAM

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin


A fake medicine that passes itself off as a real, authorised medicine. (1)

FORCES IN THE KNEE JOINT DURING EXERCISE OF TIlE KNEE EXTENSORS 1

1A Human Biology Food, Digestion and Associated Body Systems

Practicum Evaluation Form - Formative Assessment

Transcription:

SOLUBLE URANIUM DEFINITION FOR REGULATORY COMPLIANCE Rland Benke, Ph.D., CHP (Center fr Nuclear Waste Regulatry Analyses) Tanya Oxenberg, Ph.D. (U.S. Nuclear Regulatry Cmmissin) James Webb (U.S. Nuclear Regulatry Cmmissin) 2014 Health Physics Sciety s Radiatin Safety Cnference (July 13 17, 2014)

Backgrund Uranium extractin practices have evlved ver decades Existing regulatry guidance is being expanded t address in-situ recvery prcesses and peratins CNWRA and U.S. Nuclear Regulatry Cmmissin (USNRC) are updating Regulatry Guide 8.30, Health Physics Surveys in Uranium Recvery Facilities 2

Regulatry Limits Radilgical and chemical txicity cnsideratins apply t ccupatinal uranium intakes Annual radiatin dse limits in 10 CFR 20.1201 Weekly intake limit f 10 mg f sluble uranium per 10 CFR 20.1201(e) Occupatinal limits fr sluble uranium exist t prevent chemical txicity effects n kidney functin due t uranium accumulatin in the kidney and its persistence with time 3

Regulatry Definitin Gap In peratinal settings at uranium recvery facilities, uranium tends t be a mixture f chemical cmpunds and multiple inhalatin classes. Uranium re is an exceptin; singular inhalatin class W applies N sluble uranium definitin in 10 CFR Part 20 Guidance needed n which inhalatin classes relate t sluble uranium s that weekly ccupatinal intakes can be cmpared t the 10-mg limit specified in 10 CFR 20.1201(e) 4

Recmmended Definitin Recmmended definitin fr sluble uranium INHALATION CLASS BLOOD UPTAKE FRACTION, f 1 REGULATORY POSITION D 0.05 Sluble W 0.05 Sluble Y 0.002 Insluble Technical basis addressed by remainder f presentatin 5

Bikinetic Mdeling Bikinetic mdels represent the human bdy by a grup f intercnnected cmpartments. Regins f the human respiratry system Organs (e.g., kidney) Transfer rates specified between cmpartments Cmpute transfer t, accumulatin in, and remval r excretin frm cmpartments 6

Uranium Cncentratin in the Kidney Bikinetic mdeling fr uranium has been described. NUREG 0874, Internal Dsimetry Mdel fr Applicatins t Biassay at Uranium Mills, U.S. Nuclear Regulatry Cmmissin, Washingtn, DC, July 1986. Calculated kidney cncentratins Varius uranium cmpund mixtures Inhalatin and ingestin Single and cntinuus intakes 7

Internal Dsimetry Calculatin Influenced by aersl particle size and chemical frm Aersl depsitin fractins influenced by particle size Transfer rates amng cmpartments influenced by chemical frm (Inhalatin classes) 8

Internal Dsimetry Calculatin 3 pathways via lung cmpartments thrugh bld Many distinct pathways t kidney NP,B TB,B P,B NP,B TB,B P,B Calculated time dependent slutin fr each pathway 9

Internal Dsimetry Calculatin 3 pathways via lung cmpartments thrugh gastrintestinal tract (4 slutins) Many distinct pathways t kidney NP,B NP,GI TB,GI P,GI TB,B P,B NP,GI TB,GI P,GI(fast) P,GI(slw) Calculated time dependent slutin fr each pathway 10

Internal Dsimetry Calculatin 1 pathway via pulmnary lung thrugh lymph nde and bld P,L,B Many distinct pathways t kidney NP,B TB,B P,B NP,GI TB,GI P,GI(fast) P,GI(slw) P,L,B Calculated time dependent slutin fr each pathway 11

Internal Dsimetry Calculatin NP,B,S TB,B,S P,B,S Many distinct pathways t kidney NP,B NP,B,S TB,B TB,B,S P,B P,B,S NP,GI TB,GI P,GI(fast) P,GI(slw) P,L,B Calculated time dependent slutin fr each pathway 3 additinal systemic pathways via bld and ther rgans 12

Internal Dsimetry Calculatin NP,GI,S TB,GI,S P,GI,S Many distinct pathways t kidney NP,B NP,B,S TB,B TB,B,S P,B P,B,S NP,GI NP,GI,S TB,GI TB,GI,S P,GI(fast) P,GI(fast),S P,GI(slw) P,GI(slw),S P,L,B Calculated time dependent slutin fr each pathway 3 additinal systemic pathways via gastrintestinal tract and ther rgans (4 slutins) 13

Internal Dsimetry Calculatin P,L,B,S Many distinct pathways t kidney NP,B NP,B,S TB,B TB,B,S P,B P,B,S NP,GI NP,GI,S TB,GI TB,GI,S P,GI(fast) P,GI(fast),S P,GI(slw) P,GI(slw),S P,L,B P,L,B,S Calculated time dependent slutin fr each pathway 1 additinal systemic pathway via lymph nde, bld, and ther rgans 14

Cntinuus Inhalatin: 2-Cmpartment Slutin Presenting examples fr cntinuus inhalatin intake In-viv pathways dictate number f cmpartments and slutins Fractinal transfer thrugh bld and gastrintestinal tract (GI) des nt require separate cmpartment mdeling C 1 Intake rate Lung cmpartment C 2 λ 1 Kidney via bld r via GI and bld λ 2 Kidney Intake rate 1 1 15

Cntinuus Inhalatin: 3-Cmpartment Slutin C 1 Intake rate Lung cmpartment C 2 λ 1 Lymph nde C 3 λ 2 Kidney via bld r via GI and bld via bld C 1 Intake rate Lung cmpartment C 2 λ 1 Systemic, rgans ther than kidney C 3 λ 2 Kidney λ 3 λ 3 Kidney Intake rate 1 16

Cntinuus Inhalatin: 4-Cmpartment Slutin Cntinuus inhalatin intake Applied 2-, 3-, and 4- cmpartment slutins fr fractinal cntributins f each inhalatin class in the uranium mixture Class D (n pathway cntributins frm pulmnary lung t gastrintestinal tract) Class W Class Y C 1 Intake rate Lung cmpartment C 2 λ 1 Lymph nde C 3 λ 2 Systemic, rgans ther than kidney C 4 λ 3 Kidney via bld r via GI and bld via bld via bld Kidney Intake rate 1 λ 4 17

Selected Results fr Inhalatin Intakes Kidney Burden (Uranium Mass in Kidney per Unit Intake Mass) Kidney Burden (Uranium Mass in Kidney per Unit Daily Intake Mass) 1 0.1 0.01 0.001 0.0001 0.00001 0.000001 10 1 0.1 0.01 0.001 0.0001 0.00001 0.000001 Single Inhalatin Intake 100 % Class Y 100 % Class W 100 % Class D 1 10 100 1,000 Time (days) Cntinuus Inhalatin Intake 100 % Class Y 100 % Class W 100 % Class D 1 10 100 1,000 10,000 Time (days) Class D Readily transferred t kidney Class W Lesser effectiveness fr elevating uranium cncentratins in the kidney Class Y Least effectiveness Lwer by mre than an rder f magnitude at shrter times Increased cntributin at lnger times Fr single intake, lng-term kidney burden is significantly lwer than shrt-term values Fr cntinuus intake, lng-term burden is significantly lwer cmpared t burden frm mre sluble cmpunds 18

Selected Results fr Ingestin Intakes Kidney Burden (Uranium Mass in Kidney per Unit Intake Mass) Kidney Burden (Uranium Mass in Kidney per Unit Daily Intake Mass) 1 0.1 0.01 0.001 0.0001 0.00001 0.000001 1 0.1 0.01 0.001 0.0001 1E-05 1E-06 Single Ingestin Intake 100 % Class Y 1 10 100 1,000 100 % Class D 100 % Class D Time (days) 100 % Class Y 1 10 100 1,000 Time (days) 100 % Class W Cntinuus Ingestin Intake 100 % Class W Ingestin less effective cmpared t inhalatin Classes D and W mre readily transferred t kidney Same behavir fr Classes D and W fllwing ingestin Substantially smaller cntributins frm Class Y 19

Selected Inhalatin Results fr Uranium Mixture Kidney Burden (Uranium Mass in Kidney per Unit Intake Mass) Kidney Burden (Uranium Mass in Kidney per Daily Mass Intake) 0.1 0.01 0.001 0.0001 0.00001 0.000001 1 0.1 0.01 0.001 0.0001 Single Inhalatin Intake Ttal (All Classes) Class W Cntributin Class Y Cntributin 1 10 100 1,000 Ttal (All Classes) Time (days) Cntinuus Inhalatin Intake 1 10 100 1,000 10,000 Time (days) Class W Cntributin Class Y Cntributin Uranium cmpund mixture Class D Class W Class Y Class D Dminant cntributin t maximum kidney burden Class W Small cntributin Class Y Negligible cntributin 20

Selected Ingestin Results fr Uranium Mixture Kidney Burden (Uranium Mass in Kidney per Unit Intake Mass) Kidney Burden (Uranium Mass in Kidney per Daily Mass Intake) 0.1 0.01 0.001 0.0001 0.00001 0.000001 1 0.1 0.01 0.001 0.0001 0.00001 0.000001 Single Ingestin Intake Ttal (All Classes) Class W Cntributin Class Y Cntributin 1 10 100 1,000 Time (days) Cntinuus Ingestin Intake Ttal (All Classes) 1 10 100 1,000 10,000 Time (days) Class W Cntributin Class Y Cntributin Uranium cmpund mixture Class D Class W Class Y Classes D & W Significant (equal) cntributins t maximum kidney burden Class Y Negligible cntributin 21

Raditxicity vs. Chemtxicity Bikinetic mdeling f maximum kidney burden prvides technical basis frm chemtxic perspective Radilgical limits als apply t uranium intakes Mst restrictive limit (radilgical r chemical) depends n relative abundances f the different uranium cmpunds Applying the recmmended sluble uranium definitin fr the inhalatin f sluble and insluble mixtures Raditxicity is limiting when Class Y abundance > ~9 percent Chemtxicity is limiting when Class Y abundance < ~9 percent 22

Cnclusins Calculatin results supprt defining sluble uranium as thse chemical cmpunds assciated with Inhalatin Classes D and W and bld uptake fractins f 0.05. Class Y cmpunds with a bld uptake fractin f 0.002 are insluble and prvide small cntributins t the maximum uranium cncentratin in the kidney. Neglecting the insluble cntributin t the uranium cncentratin in the kidney is acceptable because raditxicity is mre limiting than chemical txicity fr inhaled mixtures f sluble and insluble uranium with significant Class Y cntributins. 23

Acknwledgement This presentatin is an independent prduct f the Center fr Nuclear Waste Regulatry Analyses and des nt necessarily reflect the view r regulatry psitin f USNRC. The USNRC staff views expressed herein are preliminary and d nt cnstitute a final judgment r determinatin f the matters addressed r f the acceptability f any licensing actin that may be under cnsideratin at USNRC. 24